Hyderabad: Dr Reddy’s Labs has announced that Jayanth Sridhar has resigned from the position of Global Head of Biologics of the Company to pursue aspirations outside the Company.
He will cease to be in employment and Senior Management Personnel of the Company, effective from the close of business hours on January 31, 2026.
Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy’s Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
Read also: Dr. Reddy’s Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment
